COST-UTILITY ANALYSIS OF ISTENT INJECT IN MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA IN JAPAN

被引：0
|
作者：
Igarashi, A. [1 ]
Falvey, H. [2 ]
Chu, A. [3 ]
Ueyama, M. [4 ]
Zhou, J. [5 ]
Onishi, Y. [4 ]
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Glaukos Corp, San Clemente, CA USA
[3] Glaukos Singapore, Singapore, Singapore
[4] Creat Ceut KK, Tokyo, Japan
[5] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD13
引用
收藏
页码：S671 / S671
页数：1
相关论文
共 50 条
  • [1] iStent inject® and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis
    Igarashi, Ataru
    Ishida, Kyoko
    Shoji, Nobuyuki
    Chu, Alice
    Falvey, Heather
    Han, Ru
    Ueyama, Maki
    Onishi, Yoshie
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (06) : 954 - 961
  • [2] iStent inject~? and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis
    Ataru Igarashi
    Kyoko Ishida
    Nobuyuki Shoji
    Alice Chu
    Heather Falvey
    Ru Han
    Maki Ueyama
    Yoshie Onishi
    International Journal of Ophthalmology, 2022, 15 (06) : 954 - 961
  • [3] A COST-UTILITY ANALYSIS OF THE ISTENT INJECT TRABECULAR MICRO-BYPASS SYSTEM PLUS CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA IN FRANCE
    Mudd, A.
    Nieland, K.
    Kleintjens, J.
    Gicquel, G.
    Falvey, H.
    VALUE IN HEALTH, 2018, 21 : S362 - S363
  • [4] OMNI® surgical system versus iStent inject® with concomitant cataract surgery for the treatment of mild-to-moderate primary open-angle glaucoma in the United States: a cost utility analysis
    Longo, Roberta
    Ghinelli, Federico
    Torelli, Francesca
    Mader, Gregory
    Masseria, Cristina
    Patel, Chad
    Franic, Duska M.
    Dickerson, Jamie
    Nguyen, Dan
    Cantor, Louis
    EXPERT REVIEW OF OPHTHALMOLOGY, 2023, 18 (02) : 135 - 142
  • [5] A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
    Nieland, Kaspar
    Labbe, Antoine
    Schweitzer, Cedric
    Gicquel, Gaetan
    Kleintjens, Joris
    Ostawal, Amrita
    Treur, Maarten
    Falvey, Heather
    PLOS ONE, 2021, 16 (06):
  • [6] Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
    Li, Ruyue
    Zhang, Kaiwen
    Lu, Zhecheng
    Mou, Dapeng
    Wang, Jin
    Li, Huiqi
    Fan, Sujie
    Wang, Ningli
    Liu, Hanruo
    BMJ OPEN, 2023, 13 (09):
  • [7] A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA
    Ahmed, I. I.
    Goeree, R.
    Patel, V
    Murray, J.
    Falvey, H.
    Podbielski, D. W.
    VALUE IN HEALTH, 2018, 21 : S161 - S162
  • [8] A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma
    Ahmed, Iqbal Ike K.
    Podbielski, Dominik W.
    Patel, Vardhaman
    Falvey, Heather
    Murray, Judith
    Botteman, Marc
    Goeree, Ron
    OPHTHALMOLOGY GLAUCOMA, 2020, 3 (02): : 103 - 113
  • [9] A COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA IN FRANCE
    Nieland, K.
    Kleintjens, J.
    Gicquel, G.
    Falvey, H.
    VALUE IN HEALTH, 2019, 22 : S219 - S219
  • [10] Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy
    Antonio Maria Fea
    Francesco Cattel
    Stefano Gandolfi
    Giorgio Buseghin
    Gianluca Furneri
    Ciro Costagliola
    BMC Health Services Research, 21
12345